New study finds no link between teen tech use and mental health problems

Over the past century there have been frequent societal concerns over the impact of novel technologies on the well-being of young people. Yet, as time passed, those concerns were consistently forgotten and apprehensions quickly shifted to the next new … Continue reading New study finds no link between teen tech use and mental health problems

New malaria vaccine reports milestone 77 percent efficacy

Results from a phase 2b trial testing a new malaria vaccine have been published revealing an impressive 77 percent efficacy, higher than any prior vaccine trialed. The vaccine is the first to reach a World Health Organization goal of at least 75 percen… Continue reading New malaria vaccine reports milestone 77 percent efficacy

Oxford immune response trial to reinfect recovered COVID-19 patients

UK researchers are set to purposely re-infect a cohort of recovered COVID-19 patients in order to study how the immune system responds to a second encounter with SARS-CoV-2. This human challenge trial expands on an ongoing study deliberately infecting … Continue reading Oxford immune response trial to reinfect recovered COVID-19 patients

Landmark study finds link between playing video games and well-being

A first-of-its-kind study from Oxford University has investigated the relationship between well-being and time spent playing video games using novel industry data from two popular video games. The surprising findings revealed a small correlation betwee… Continue reading Landmark study finds link between playing video games and well-being

Oxford’s COVID-19 vaccine trial delivers encouraging interim results

AstraZeneca and the University of Oxford have presented the first interim data from their Phase 3 COVID-19 vaccine trial. The vaccine is safe, up to 90 percent effective, and significantly easier to distribute compared to other options requiring comple… Continue reading Oxford’s COVID-19 vaccine trial delivers encouraging interim results

Oxford study links COVID-19 with increased rates of mental illness

A new large-scale analysis of US patient data has found nearly one in five people are diagnosed with a psychiatric illness within three months of a positive COVID-19 test. The Oxford University led study suggests recovered COVID patients are twice as l… Continue reading Oxford study links COVID-19 with increased rates of mental illness

Oxford study links COVID-19 with increased rates of mental illness

A new large-scale analysis of US patient data has found nearly one in five people are diagnosed with a psychiatric illness within three months of a positive COVID-19 test. The Oxford University led study suggests recovered COVID patients are twice as l… Continue reading Oxford study links COVID-19 with increased rates of mental illness

University Email Hijacking Attacks Push Phishing, Malware

Attackers are compromising email accounts from popular universities, including Purdue and Oxford, to launch attacks that get around DMARC and SPF. Continue reading University Email Hijacking Attacks Push Phishing, Malware

Promising “molecular tweezer” Parkinson’s therapy looks to human trials

A novel therapy using molecular tweezers has proven safe and effective in animal models and researchers are now looking ahead to human trials

New research published in the journal Nature Communications reveals a novel drug, designed to break up the aggregations of toxic proteins associated with Parkinson’s disease, can effectively slow the disease in mouse models. The researchers are now looking at moving toward human trials.

Continue Reading

Category: Medical, Science

Tags: , , , , , ,

Continue reading Promising “molecular tweezer” Parkinson’s therapy looks to human trials

Oxford’s COVID-19 vaccine trial resumes in UK

Following a swift independent investigation by the Medicines Health Regulatory Authority (MHRA), large-scale Phase 3 trials for a COVID-19 vaccine developed by scientists at the University of Oxford, are recommencing across the United Kingdom after a s… Continue reading Oxford’s COVID-19 vaccine trial resumes in UK